Identification of putative genetic modifying factors that influence the development of Papillon-Lefévre or Haim-Munk syndrome phenotypes.
Autorzy:
Pap ÉM; Department of Obstetrics and Gynecology Szeged, University of Szeged, Szeged, Hungary. FarkasK; Department of Medical Genetics, University of Szeged, Szeged, Hungary. Tóth L; Department of Medical Genetics, University of Szeged, Szeged, Hungary. Fábos B; Mór Kaposi Teaching Hospital, Kaposvár, Hungary. Széll M; Department of Medical Genetics, University of Szeged, Szeged, Hungary.; Dermatological Research Group of the Hungarian Academy of Sciences, University of Szeged, Szeged, Hungary. Németh G; Department of Obstetrics and Gynecology Szeged, University of Szeged, Szeged, Hungary. Nagy N; Department of Medical Genetics, University of Szeged, Szeged, Hungary.; Dermatological Research Group of the Hungarian Academy of Sciences, University of Szeged, Szeged, Hungary.
Atypical neurofibromatosis type 1 with unilateral limb hypertrophy mimicking overgrowth syndrome.
Autorzy:
Tripolszki K; Department of Medical Genetics, University of Szeged, Szeged, Hungary. FarkasK; MTA-SZTE Dermatological Research Group, University of Szeged, Szeged, Hungary. Sulák A; Department of Medical Genetics, University of Szeged, Szeged, Hungary. Szolnoky G; Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary. Duga B; Department of Medical Genetics, University of Pécs, Pécs, Hungary. Melegh B; Department of Medical Genetics, University of Pécs, Pécs, Hungary. Knox RG; Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke's Hospital Cambridge, Cambridge, UK. Parker VER; Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke's Hospital Cambridge, Cambridge, UK. Semple RK; Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke's Hospital Cambridge, Cambridge, UK. Kemény L; MTA-SZTE Dermatological Research Group, University of Szeged, Szeged, Hungary.; Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary. Széll M; Department of Medical Genetics, University of Szeged, Szeged, Hungary.; MTA-SZTE Dermatological Research Group, University of Szeged, Szeged, Hungary. Nagy N; Department of Medical Genetics, University of Szeged, Szeged, Hungary.; MTA-SZTE Dermatological Research Group, University of Szeged, Szeged, Hungary.; Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary.
Prediction of Short- and Medium-term Efficacy of Biosimilar Infliximab Therapy. Do Trough Levels and Antidrug Antibody Levels or Clinical And Biochemical Markers Play the More Important Role?
Autorzy:
Gonczi L; First Department of Internal Medicine, Semmelweis University, Budapest, Hungary. Vegh Z; First Department of Internal Medicine, Semmelweis University, Budapest, Hungary. Golovics PA; First Department of Internal Medicine, Semmelweis University, Budapest, Hungary. Rutka M; First Department of Medicine, University of Szeged, Szeged, Hungary. Gecse KB; First Department of Internal Medicine, Semmelweis University, Budapest, Hungary. Bor R; First Department of Medicine, University of Szeged, Szeged, Hungary. FarkasK; First Department of Medicine, University of Szeged, Szeged, Hungary. Szamosi T; Military Hospital - State Health Centre, Budapest, Hungary. Bene L; First Department of Medicine, Peterfy Hospital, Budapest, Hungary. Gasztonyi B; Second Department of Medicine, Zala County Hospital, Zalaegerszeg, Hungary. Kristóf T; Second Department of Medicine, B-A-Z County and University Teaching Hospital, Miskolc, Hungary. Lakatos L; Department of Internal Medicine, Csolnoky Ferenc Regional Hospital, Veszprém, Hungary. Miheller P; Second Department of Internal Medicine, Semmelweis University, Budapest, Hungary. Palatka K; Institute of Medicine, Department of Gastroenterology, University of Debrecen, Clinical Center, Debrecen, Hungary. Papp M; Institute of Medicine, Department of Gastroenterology, University of Debrecen, Clinical Center, Debrecen, Hungary. Patai Á; Department of Medicine and Gastroenterology, Markusovszky Hospital, Szombathely, Hungary. Salamon Á; Department of Gastroenterology, Tolna County Teaching Hospital, Szekszárd, Hungary. Tóth GT; Department of Gastroenterology, Janos Hospital, Budapest, Hungary. Vincze Á; First Department of Medicine, University of Pécs, Pécs, Hungary. Biro E; Department of Laboratory Medicine, Semmelweis University, Budapest, Hungary. Lovasz BD; First Department of Internal Medicine, Semmelweis University, Budapest, Hungary. Kurti Z; First Department of Internal Medicine, Semmelweis University, Budapest, Hungary. Szepes Z; First Department of Medicine, University of Szeged, Szeged, Hungary. Molnár T; First Department of Medicine, University of Szeged, Szeged, Hungary. Lakatos PL; First Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
One mutation, two phenotypes: a single nonsense mutation of the CTSC gene causes two clinically distinct phenotypes.
Autorzy:
Sulák A; Department of Medical Genetics, University of Szeged, Szeged, Hungary. Tóth L; Department of Medical Genetics, University of Szeged, Szeged, Hungary. FarkasK; MTA SZTE Dermatological Research Group, University of Szeged, Szeged, Hungary. Tripolszki K; Department of Medical Genetics, University of Szeged, Szeged, Hungary. Fábos B; Mór Kaposi Teaching Hospital, Kaposvár, Hungary. Kemény L; MTA SZTE Dermatological Research Group, University of Szeged, Szeged, Hungary.; Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary. Vályi P; Department of Parodontology, Faculty of Dentistry, University of Szeged, Szeged, Hungary. Nagy K; Department of Parodontology, Faculty of Dentistry, University of Szeged, Szeged, Hungary. Nagy N; Department of Medical Genetics, University of Szeged, Szeged, Hungary.; MTA SZTE Dermatological Research Group, University of Szeged, Szeged, Hungary.; Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary. Széll M; Department of Medical Genetics, University of Szeged, Szeged, Hungary.; MTA SZTE Dermatological Research Group, University of Szeged, Szeged, Hungary.
Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort.
Autorzy:
Gecse KB; First Department of Internal Medicine, Semmelweis University, Budapest, Hungary. Lovász BD; First Department of Internal Medicine, Semmelweis University, Budapest, Hungary. FarkasK; First Department of Internal Medicine, University of Szeged, Szeged, Hungary. Banai J; Medical Centre, Hungarian Defence Forces, Budapest, Hungary. Bene L; First Department of Medicine, Peterfy Hospital, Budapest, Hungary. Gasztonyi B; Second Department of Medicine, Zala County Hospital, Zalaegerszeg, Hungary. Golovics PA; First Department of Internal Medicine, Semmelweis University, Budapest, Hungary. Kristóf T; Second Department of Medicine, B-A-Z County and University Teaching Hospital, Miskolc, Hungary. Lakatos L; Department of Internal Medicine, Csolnoky Ferenc Regional Hospital, Veszprém, Hungary. Csontos ÁA; Second Department of Internal Medicine, Semmelweis University, Budapest, Hungary. Juhász M; Second Department of Internal Medicine, Semmelweis University, Budapest, Hungary. Nagy F; First Department of Internal Medicine, University of Szeged, Szeged, Hungary. Palatka K; Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Hungary. Papp M; Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Hungary. Patai Á; Department of Medicine and Gastroenterology, Markusovszky Hospital, Szombathely, Hungary. Lakner L; Department of Medicine and Gastroenterology, Markusovszky Hospital, Szombathely, Hungary. Salamon Á; Department of Gastroenterology, Tolna County Teaching Hospital, Szekszárd, Hungary. Szamosi T; Medical Centre, Hungarian Defence Forces, Budapest, Hungary. Szepes Z; First Department of Internal Medicine, University of Szeged, Szeged, Hungary. Tóth GT; Department of Gastroenterology, Janos Hospital, Budapest, Hungary. Vincze Á; First Department of Medicine, University of Pécs, Pécs, Hungary. Szalay B; Department of Laboratory Medicine, Semmelweis University, Budapest, Hungary. Molnár T; First Department of Internal Medicine, University of Szeged, Szeged, Hungary. Lakatos PL; First Department of Internal Medicine, Semmelweis University, Budapest, Hungary lakatos.peter_.
Pokaż więcej
Źródło:
Journal of Crohn's & colitis [J Crohns Colitis] 2016 Feb; Vol. 10 (2), pp. 133-40. Date of Electronic Publication: 2015 Dec 10.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
